Inhibrx Announces Details of Presentations at 2022 AACR Annu

/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development and an emerging pre-clinical pipeline,...

Related Keywords

United States , American , Heather Kinkead , Katelynm Willis , Brendan Eckelman , Bristol Myers Squibb , Prnewswire Inhibrx Inc , American Association For Cancer Research , Inhibrx Inc , Nasdaq , Cancer Research , Annual Meeting , New Orleans , Inhibrx Co Founder , Chief Scientific , Exhibit Halls , Poster Section , Media Contact ,